<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-1751</journal-id>
<journal-title><![CDATA[Revista Colombiana de Estadística]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Colomb.Estad.]]></abbrev-journal-title>
<issn>0120-1751</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Estadística - Universidad Nacional de Colombia.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-17512018000200191</article-id>
<article-id pub-id-type="doi">10.15446/rce.v41n2.63332</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Construction of the Design Matrix for Generalized Linear Mixed-Effects Models in the Context of Clinical Trials of Treatment Sequences]]></article-title>
<article-title xml:lang="es"><![CDATA[Construcción de la matriz de diseño en modelos lineales de efectos mixtos generalizados en un contexto de ensayos clínicos de secuencias de tratamientos]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[Francisco J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,The University of Kansas Medical Center  ]]></institution>
<addr-line><![CDATA[Kansas City Kansas]]></addr-line>
<country>USA</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>41</volume>
<numero>2</numero>
<fpage>191</fpage>
<lpage>233</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-17512018000200191&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-17512018000200191&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-17512018000200191&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The estimation of carry-over effects is a di-cult problem in the design and analysis of clinical trials of treatment sequences including cross-over trials. Except for simple designs, carry-over effects are usually unidentifiable and therefore nonestimable. Solutions such as imposing parameter constraints are often unjustified and produce differing carry-over estimates depending on the constraint imposed. Generalized inverses or treatment-balancing often allow estimating main treatment eects, but the problem of estimating the carry-over contribution of a treatment sequence remains open in these approaches. Moreover, washout periods are not always feasible or ethical. A common feature of designs with unidentifiable parameters is that they do not have design matrices of full rank. Thus, we propose approaches to the construction of design matrices of full rank, without imposing artificial constraints on the carry-over effects. Our approaches are applicable within the framework of generalized linear mixed-effects models. We present a new model for the design and analysis of clinical trials of treatment sequences, called Antichronic System, and introduce some special sequences called Skip Sequences. We show that carry-over effects are identifiable only if appropriate Skip Sequences are used in the design and/or data analysis of the clinical trial. We explain how Skip Sequences can be implemented in practice, and present a method of computing the appropriate Skip Sequences. We show applications to the design of a cross-over study with 3 treatments and 3 periods, and to the data analysis of the STAR*D study of sequences of treatments for depression.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La estimación de los efectos de arrastre es un problema difícil en el diseño y análisis de ensayos clínicos de secuencias de tratamientos, incluyendo ensayos cruzados. Excepto por diseños simples, estos efectos son usualmente no identificables y, por lo tanto, no estimables. La imposición de restricciones a los parámetros es a menudo no justificada y produce diferentes estimativos de los efectos de arrastre dependiendo de la restricción impuesta. Las inversas generalizadas o el balance de tratamientos a menudo permiten estimar los efectos principales de tratamiento, pero no resuelven el problema de estimar la contribución de los efectos de arrastre de una sequencia de tratamiento. Además, los períodos de lavado no siempre son factibles o éticos. Los diseños con parámetros no identificables comúnmente tienen matrices de diseño que no son de rango completo. Por lo tanto, proponemos métodos para la construcción de matrices de rango completo, sin imponer restricciones artificiales en los efectos de arrastre. Nuestros métodos son aplicables en un contexto de modelos lineales mixtos generalizados. Presentamos un nuevo modelo para el diseño y análisis de ensayos clínicos de secuencias de tratamientos, llamado Sistema Anticrónico, e introducimos secuencias de tratamiento especiales llamadas Secuencias de Salto. Demostramos que los efectos de arrastre son identificables sólo si se usan Secuencias de Salto apropiadas. Explicamos como implementar en la práctica estas secuencias, y presentamos un método para calcular las secuencias apropiadas. Presentamos aplicaciones al diseño de un estudio cruzado con 3 tratamientos y 3 períodos, y al análisis del estudio STAR*D de secuencias de tratamientos para la depresión.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Augmented regression]]></kwd>
<kwd lng="en"><![CDATA[carry-over effects]]></kwd>
<kwd lng="en"><![CDATA[cross-over design]]></kwd>
<kwd lng="en"><![CDATA[design matrix]]></kwd>
<kwd lng="en"><![CDATA[estimability]]></kwd>
<kwd lng="en"><![CDATA[generalized inverses]]></kwd>
<kwd lng="en"><![CDATA[generalized least squares]]></kwd>
<kwd lng="en"><![CDATA[identifiability]]></kwd>
<kwd lng="en"><![CDATA[maximum likelihood]]></kwd>
<kwd lng="en"><![CDATA[placebo]]></kwd>
<kwd lng="en"><![CDATA[quasi-likelihood]]></kwd>
<kwd lng="en"><![CDATA[random effects linear models]]></kwd>
<kwd lng="en"><![CDATA[robust fixed-effects estimators]]></kwd>
<kwd lng="es"><![CDATA[Cuasi-verosimilitud]]></kwd>
<kwd lng="es"><![CDATA[diseño cruzado]]></kwd>
<kwd lng="es"><![CDATA[efectos de arrastre]]></kwd>
<kwd lng="es"><![CDATA[estimabilidad]]></kwd>
<kwd lng="es"><![CDATA[estimadores robustos de efectos fijos]]></kwd>
<kwd lng="es"><![CDATA[identificabilidad]]></kwd>
<kwd lng="es"><![CDATA[inversas generalizadas]]></kwd>
<kwd lng="es"><![CDATA[matriz de diseño]]></kwd>
<kwd lng="es"><![CDATA[máxima verosimilitud]]></kwd>
<kwd lng="es"><![CDATA[mínimos cuadrados generalizados]]></kwd>
<kwd lng="es"><![CDATA[modelos lineales de efectos aleatorios]]></kwd>
<kwd lng="es"><![CDATA[placebo]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abeyasekera]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Curnow]]></surname>
<given-names><![CDATA[R. N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The desirability of adjusting for residual effects in a crossover design]]></article-title>
<source><![CDATA[Biometrics]]></source>
<year>1984</year>
<volume>40</volume>
<page-range>1071-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berg]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Welty]]></surname>
<given-names><![CDATA[T. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gidal]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[F. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Krebill]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Szaarski]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Dworetzky]]></surname>
<given-names><![CDATA[B. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pollard]]></surname>
<given-names><![CDATA[J. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Elder Jr]]></surname>
<given-names><![CDATA[E. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Switzer]]></surname>
<given-names><![CDATA[R. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Privitera]]></surname>
<given-names><![CDATA[M. D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioequivalence between generic and branded lamotrigine in people with epilepsy: the EQUIGEN randomized clinical trial]]></article-title>
<source><![CDATA[JAMA Neurology]]></source>
<year>2017</year>
<volume>74</volume>
<page-range>919-26</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Botts]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Santoro]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Spina]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Muscatello]]></surname>
<given-names><![CDATA[M. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Cogollo]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[F. E.]]></given-names>
</name>
<name>
<surname><![CDATA[de Leon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimating the eects of co-medications on plasma olanzapine concentrations by using a mixed model]]></article-title>
<source><![CDATA[Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry]]></source>
<year>2008</year>
<volume>32</volume>
<page-range>1453-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Breslow]]></surname>
<given-names><![CDATA[N. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Clayton]]></surname>
<given-names><![CDATA[D. G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Approximate inference in generalized linear mixed models]]></article-title>
<source><![CDATA[Journal of the American Statistical Association]]></source>
<year>1993</year>
<volume>88</volume>
<page-range>9-25</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bronson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Matrix Operations, 1st Edition. Schaum's Outline Series]]></source>
<year>1989</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[McGraw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="">
<collab>Center for Drug Evaluation and Research</collab>
<source><![CDATA[US Food and Drug Administration. Guidance for Industry: Statistical Approaches to Establishing Bioequivalence]]></source>
<year>2001</year>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="">
<collab>Center for Drug Evaluation and Research</collab>
<source><![CDATA[US Food and Drug Administration. Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations]]></source>
<year>2003</year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Christensen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Plane Answers to Complex Questions: The Theory of Linear Models]]></source>
<year>2011</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[F. J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Measuring the Individual Benet of a Medical or Behavioral Treatment Using Generalized Linear Mixed-Eects Models]]></article-title>
<source><![CDATA[Statistics in Medicine]]></source>
<year>2016</year>
<volume>35</volume>
<page-range>4077-92</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[F. J]]></given-names>
</name>
</person-group>
<source><![CDATA[Estimating individual benets of medical or behavioral treatments in severely ill patients]]></source>
<year></year>
<publisher-name><![CDATA[Statistical Methods in Medical Research]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[F. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Berg]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Krebill]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Welty]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Gidal]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Alloway]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Privitera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Random-effects linear modeling and sample size tables for two special cross-over designs of average bioequivalence studies: the 4-period, 2-sequence, 2-formulation and 6-period, 3-sequence, 3-formulation designs]]></article-title>
<source><![CDATA[Clinical Pharmacokinetics]]></source>
<year>2013</year>
<volume>52</volume>
<page-range>1033-43</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ebbes]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Bockenholt]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
<name>
<surname><![CDATA[Wedel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regressor and random-effects dependencies in multilevel models]]></article-title>
<source><![CDATA[Statistica Neerlandica]]></source>
<year>2004</year>
<volume>58</volume>
<page-range>161-78</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fava]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rush]]></surname>
<given-names><![CDATA[A. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Trivedi]]></surname>
<given-names><![CDATA[M. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Nierenberg]]></surname>
<given-names><![CDATA[A. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Thase]]></surname>
<given-names><![CDATA[M. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Sackeim]]></surname>
<given-names><![CDATA[H. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Quitkin]]></surname>
<given-names><![CDATA[F. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Wisniewski]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Lavori]]></surname>
<given-names><![CDATA[P. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenbaum]]></surname>
<given-names><![CDATA[J. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Kupfer]]></surname>
<given-names><![CDATA[D. J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study]]></article-title>
<source><![CDATA[Psychiatric clinics of North America]]></source>
<year>2003</year>
<volume>26</volume>
<page-range>457-94</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fitzmaurice]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Molenberghs]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Advances in longitudinal data analysis: An historical perspective]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Fitzmaurice]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Davidian]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Verbeke]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Molenberghs]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Longitudinal Data Analysis]]></source>
<year>2004</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Chapman &amp; Hall/CRC. London: Chapman &amp; Hall/CRC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fleiss]]></surname>
<given-names><![CDATA[J. L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A critique of recent research on the two-treatment Crossover design]]></article-title>
<source><![CDATA[Controlled Clinical Trials]]></source>
<year>1989</year>
<volume>10</volume>
<page-range>237-43</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frees]]></surname>
<given-names><![CDATA[E. W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Omitted variables in longitudinal data models]]></article-title>
<source><![CDATA[The Canadian Journal of Statistics]]></source>
<year>2001</year>
<volume>29</volume>
<page-range>573-95</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frees]]></surname>
<given-names><![CDATA[E. W]]></given-names>
</name>
</person-group>
<source><![CDATA[Longitudinal and Panel Data]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grajales]]></surname>
<given-names><![CDATA[L. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[L. A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Data imputation in switchback designs using a mixed model with correlated errors]]></article-title>
<source><![CDATA[Revista colombiana de estadística]]></source>
<year>2006</year>
<volume>29</volume>
<page-range>221-38</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hausman]]></surname>
<given-names><![CDATA[J. A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Specication tests in econometrics]]></article-title>
<source><![CDATA[Econometrica]]></source>
<year>1978</year>
<volume>46</volume>
<page-range>1251-71</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Henderson]]></surname>
<given-names><![CDATA[C. R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimation of variance and covariance components]]></article-title>
<source><![CDATA[Biometrics]]></source>
<year>1953</year>
<volume>9</volume>
<page-range>226-52</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hofmann]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Wrobel]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Kessner]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bingel]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Minimizing carryover effects after treatment failure and maximizing therapeutic outcome. Can changing the route of administration mitigate the influence of treatment history?]]></article-title>
<source><![CDATA[Zeitschrift fur Psychologie]]></source>
<year>2014</year>
<volume>222</volume>
<page-range>171-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hooks]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Marx]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Kachman]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Pedersen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimality criteria for models with random effects]]></article-title>
<source><![CDATA[Revista Colombiana de Estadística]]></source>
<year>2009</year>
<volume>32</volume>
<page-range>17-31</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huber]]></surname>
<given-names><![CDATA[P. J]]></given-names>
</name>
</person-group>
<source><![CDATA[The behavior of maximum likelihood estimates under nonstandard conditions]]></source>
<year>1967</year>
<conf-name><![CDATA[ 1of Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability]]></conf-name>
<conf-loc> </conf-loc>
<page-range>221-33</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Kenward]]></surname>
<given-names><![CDATA[M. G]]></given-names>
</name>
</person-group>
<source><![CDATA[Design and Analysis of Cross-over Trials]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Boca Raton ]]></publisher-loc>
<publisher-name><![CDATA[CRC Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J.-S.]]></given-names>
</name>
<name>
<surname><![CDATA[Frees]]></surname>
<given-names><![CDATA[E. W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Omitted variables in multilevel models]]></article-title>
<source><![CDATA[Psychometrika]]></source>
<year>2006</year>
<volume>71</volume>
<page-range>659-90</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J.-S.]]></given-names>
</name>
<name>
<surname><![CDATA[Frees]]></surname>
<given-names><![CDATA[E. W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multilevel modeling with correlated effects]]></article-title>
<source><![CDATA[Psychometrika]]></source>
<year>2007</year>
<volume>72</volume>
<page-range>505-33</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laird]]></surname>
<given-names><![CDATA[N. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ware]]></surname>
<given-names><![CDATA[J. H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Random eects models for longitudinal data]]></article-title>
<source><![CDATA[Biometrics]]></source>
<year>1982</year>
<volume>38</volume>
<page-range>963-74</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Long]]></surname>
<given-names><![CDATA[D. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Preisser]]></surname>
<given-names><![CDATA[J. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Herring]]></surname>
<given-names><![CDATA[A. H.]]></given-names>
</name>
<name>
<surname><![CDATA[Golin]]></surname>
<given-names><![CDATA[C. E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A marginalized zero-inflated Poisson regression model with random effects]]></article-title>
<source><![CDATA[Journal of the Royal Statistical Society: Series C 64]]></source>
<year>2015</year>
<page-range>815-30</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mundlak]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[On the pooling of time series and cross-section data]]></article-title>
<source><![CDATA[Econometrica]]></source>
<year>1978</year>
<volume>46</volume>
<page-range>69-85</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nelder]]></surname>
<given-names><![CDATA[J. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Wedderburn]]></surname>
<given-names><![CDATA[R. W. M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generalized linear models]]></article-title>
<source><![CDATA[Journal of the Royal Statistical Society]]></source>
<year>1972</year>
<volume>135</volume>
<page-range>370-84</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Privitera]]></surname>
<given-names><![CDATA[M. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Welty]]></surname>
<given-names><![CDATA[T. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Gidal]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[F. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Krebill]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Szaflarski]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Dworetzky]]></surname>
<given-names><![CDATA[B. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pollard]]></surname>
<given-names><![CDATA[J. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Elder]]></surname>
<given-names><![CDATA[E. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
<name>
<surname><![CDATA[Berg]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic-to-Generic Lamotrigine Switches in People with Epilepsy: A Randomized Controlled Trial]]></article-title>
<source><![CDATA[Lancet Neurology]]></source>
<year>2016</year>
<volume>15</volume>
<page-range>365-72</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabe-Hesketh]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Skrondal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generalized linear mixed-eects models]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Davidian]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Verbeke]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Molenberghs]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Longitudinal Data Analysis, Fitzmaurice]]></source>
<year>2009</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Chapman &amp; Hall/CRC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabe-Hesketh]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Skrondal]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Pickles]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Maximum likelihood estimation of limited and discrete dependent variable models with nested random effects]]></article-title>
<source><![CDATA[Journal of Econometrics]]></source>
<year>2005</year>
<volume>128</volume>
<page-range>301-23</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Searle]]></surname>
<given-names><![CDATA[S. R]]></given-names>
</name>
</person-group>
<source><![CDATA[Matrix Algebra for the Biological Sciences]]></source>
<year>1966</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Wiley]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Senn]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Cross-over Trials in Clinical Research]]></source>
<year>2002</year>
<edition>2nd Edition</edition>
<publisher-loc><![CDATA[Hoboken ]]></publisher-loc>
<publisher-name><![CDATA[Wiley]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Senn]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[D'Angelo]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Potvin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carry-over in cross-over trials in bioequivalence: theoretical concerns and empirical evidence]]></article-title>
<source><![CDATA[Pharmaceutical Statistics]]></source>
<year>2004</year>
<volume>3</volume>
<page-range>133-42</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Senn]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Lambrou]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Robust and realistic approaches to carry-over]]></article-title>
<source><![CDATA[Statistics in Medicine]]></source>
<year>1998</year>
<volume>17</volume>
<page-range>2849-64</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shao]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Mathematical Statistics]]></source>
<year>2003</year>
<edition>2nd Edition</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vermunt]]></surname>
<given-names><![CDATA[J. K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mixed-effects logistic regression models for indirectly observed discrete outcome variables]]></article-title>
<source><![CDATA[Multivariate Behavioral Research]]></source>
<year>2005</year>
<volume>40</volume>
<page-range>281-301</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Maximum likelihood estimation of misspecified models]]></article-title>
<source><![CDATA[Econometrica]]></source>
<year>1982</year>
<volume>50</volume>
<page-range>1-25</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
